SGPP1 has also been shown to be a target of miR-95, which is highly expressed in ALDH+ and CD133+ subpopulations of non-small cell lung cancer (NSCLC) compared to ALDH1- and CD133-cells. This evidence concerns the gene LDHA and non-small cell lung carcinoma.